Panel 3: Genomics, precision medicine and targeted therapies
- PMID: 32007292
- PMCID: PMC7155947
- DOI: 10.1016/j.ijporl.2019.109835
Panel 3: Genomics, precision medicine and targeted therapies
Abstract
Objective: To review the most recent advances in human and bacterial genomics as applied to pathogenesis and clinical management of otitis media.
Data sources: PubMed articles published since the last meeting in June 2015 up to June 2019.
Review methods: A panel of experts in human and bacterial genomics of otitis media was formed. Each panel member reviewed the literature in their respective fields and wrote draft reviews. The reviews were shared with all panel members, and a merged draft was created. The panel met at the 20th International Symposium on Recent Advances in Otitis Media in June 2019, discussed the review and refined the content. A final draft was made, circulated, and approved by the panel members.
Conclusion: Trans-disciplinary approaches applying pan-omic technologies to identify human susceptibility to otitis media and to understand microbial population dynamics, patho-adaptation and virulence mechanisms are crucial to the development of novel, personalized therapeutics and prevention strategies for otitis media.
Implications for practice: In the future otitis media prevention strategies may be augmented by mucosal immunization, combination vaccines targeting multiple pathogens, and modulation of the middle ear microbiome. Both treatment and vaccination may be tailored to an individual's otitis media phenotype as defined by molecular profiles obtained by using rapidly developing techniques in microbial and host genomics.
Keywords: Genome-wide association study; Metagenomics; Microbiome; Otitis media; Otitis-prone; Precision medicine.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest Dr. Allen F. Ryan is a Co-founder of and equity holder in Otonomy, Inc., a company that develops slow-release compounds for local delivery of medications to the middle and inner ear. The authors declare no competing interests.
Figures


Similar articles
-
Panel 3: Genetics and Precision Medicine of Otitis Media.Otolaryngol Head Neck Surg. 2017 Apr;156(4_suppl):S41-S50. doi: 10.1177/0194599816685559. Otolaryngol Head Neck Surg. 2017. PMID: 28372532 Free PMC article. Review.
-
Panel 4: Recent advances in understanding the natural history of the otitis media microbiome and its response to environmental pressures.Int J Pediatr Otorhinolaryngol. 2020 Mar;130 Suppl 1(Suppl 1):109836. doi: 10.1016/j.ijporl.2019.109836. Epub 2019 Dec 18. Int J Pediatr Otorhinolaryngol. 2020. PMID: 31879084 Free PMC article. Review.
-
Panel 5: Microbiology and immunology panel.Otolaryngol Head Neck Surg. 2013 Apr;148(4 Suppl):E64-89. doi: 10.1177/0194599812459636. Otolaryngol Head Neck Surg. 2013. PMID: 23536533 Free PMC article. Review.
-
Panel 7 - Pathogenesis of otitis media - a review of the literature between 2015 and 2019.Int J Pediatr Otorhinolaryngol. 2020 Mar;130 Suppl 1:109838. doi: 10.1016/j.ijporl.2019.109838. Epub 2019 Dec 19. Int J Pediatr Otorhinolaryngol. 2020. PMID: 31879085 Free PMC article. Review.
-
Panel 4: Report of the Microbiology Panel.Otolaryngol Head Neck Surg. 2017 Apr;156(4_suppl):S51-S62. doi: 10.1177/0194599816639028. Otolaryngol Head Neck Surg. 2017. PMID: 28372529 Free PMC article. Review.
Cited by
-
Editorial: Otitis Media Genomics and the Middle Ear Microbiome.Front Genet. 2021 Oct 12;12:763688. doi: 10.3389/fgene.2021.763688. eCollection 2021. Front Genet. 2021. PMID: 34712274 Free PMC article. No abstract available.
-
Editorial: Otitis media susceptibility due to genetic variants.Front Genet. 2023 Dec 12;14:1341669. doi: 10.3389/fgene.2023.1341669. eCollection 2023. Front Genet. 2023. PMID: 38152651 Free PMC article. No abstract available.
-
Multi-omic studies on missense PLG variants in families with otitis media.Sci Rep. 2020 Sep 14;10(1):15035. doi: 10.1038/s41598-020-70498-w. Sci Rep. 2020. PMID: 32929111 Free PMC article.
-
Rare and low-frequency variants in families with otitis media.J Mol Med (Berl). 2025 May;103(5):559-570. doi: 10.1007/s00109-025-02537-w. Epub 2025 Apr 4. J Mol Med (Berl). 2025. PMID: 40183840
References
-
- Subcommittee on Management of Acute Otitis Media, Diagnosis and Management of Acute Otitis Media, Pediatrics 113 (2004) 1451–1465. - PubMed
-
- Lieberthal AS, Carroll AE, Chonmaitree T, Ganiats TG, Hoberman A, Jackson MA, Joffe MD, Miller DT, Rosenfeld RM, Sevilla XD, Schwartz RH, Thomas PA, Tunkel DE, The diagnosis and management of acute otitis media, Pediatrics 131 (2013) e964–e999. - PubMed
-
- Laine MK, Tahtinen PA, Ruuskanen O, Huovinen P, Ruohola A, Symptoms or symptom-based scores cannot predict acute otitis media at otitis-prone age, Pediatrics 125 (2010) e1154–e1161. - PubMed
-
- Pichichero ME, Poole MD, Assessing diagnostic accuracy and tympanocentesis skills in the management of otitis media, Arch. Pediatr. Adolesc. Med 155 (2001) 1137–1142. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous